If you've been considering a change, this could be a great time to make the move to our latest technology. Fill out the form to learn more.
Individual results may vary. The MiniMed 670G is indicated for people living with type 1 diabetes, seven years of age and older.
*90% reduction in injections assumes four injections per day for 30 days and one infusion set change every two to three days. **Data on file. 2019.
1. Mueckler, JR et al. Real-World Assessment of Former MDI Patients’ Experience on the Medtronic MiniMed™ 670G Hybrid Closed-Loop System (n=47). Poster presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2017 February 14-17, Vienna, Austria